Search
Search Results
##search.searchResults.foundPlural##
-
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1691PDF: 1929Suppl. Files: 219HTML: 111 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12963PDF: 1738HTML: 4354Cover letter: 229Figure 1: 238 -
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1280PDF: 826HTML: 257 -
The significance of purity: Leukaemias involving the erythroid lineage Erythroid lineage leukemia
891PDF: 444HTML: 367 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2127PDF: 136HTML: 41 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2184PDF: 893HTML: 366 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
1195PDF: 694HTML: 481 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2870PDF: 1020HTML: 4728 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3419PDF: 1629HTML: 289 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4878PDF: 1612HTML: 2270Untitled: 257Untitled: 274Untitled: 293Untitled: 242Untitled: 261 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1274PDF: 573HTML: 1713Figures: 195Fifures Sanz: 208tables Sanz: 211Untitled: 205 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3442PDF: 1301HTML: 8397 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2336PDF: 1037HTML: 4987 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3339PDF: 1914HTML: 3702 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2316PDF: 766HTML: 2150Untitled: 257Untitled: 177Untitled: 209Untitled: 185Untitled: 200Untitled: 211Untitled: 216 -
Anemia in the elderly: not always what it seems.
3406PDF: 1128HTML: 1805Figure 1: 215Figure 1 revised: 213 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2371PDF: 995HTML: 504Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 251UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 380Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 283Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 206Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 222Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 294 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1387PDF: 1167PDF: 924HTML: 202 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5810PDF: 1579HTML: 1666Untitled: 266 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1038PDF: 596HTML: 2227Cover Letter: 222 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2588PDF: 1372HTML: 1832CoverLetter: 209 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3397PDF: 1598HTML: 520 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1743PDF: 1046HTML: 1894Untitled: 225Untitled: 207 -
Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study
1305PDF: 523HTML: 157 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2676PDF: 1229HTML: 285 -
WHAT ARE FUNGAL INFECTIONS?
4366PDF: 2487HTML: 27704de Pauw: 271







